Bioequivalence and Bioavailability Forum

End study requirements for Brazil submission khageswara Rao 2021-07-01 08:43
- End study requirements for Brazil submission drgunasakaran1 2021-07-05 10:15

Nitrofurantoin BE study pjs 2015-07-30 08:55
- Nitrofurantoin BE study drgunasakaran1 2015-08-02 14:56
  - Nitrofurantoin BE study pjs 2015-08-03 10:06
- Nitrofurantoin BE study pjs 2015-08-07 04:10
  - Nitrofurantoin BE study pjs 2015-08-27 15:36
    - Nitrofurantoin BE study Dr_Dan 2015-08-28 09:15
      - Nitrofurantoin BE study pjs 2015-08-28 10:37
        
        Nitrofurantoin BE study Dr_Dan 2015-08-31 18:19
        
        Nitrofurantoin BE study AB661 2021-06-15 09:38
        
        Nitrofurantoin BE study Relaxation 2021-06-15 12:10
        
        Nitrofurantoin BE study AB661 2021-06-16 08:13
        
        Nitrofurantoin BE study Relaxation 2021-06-16 12:59

Number of sets selection in In-Vitro Kinetic and Equilibrium Binding study Sivakrishna 2021-06-10 08:12

Guidelines Rams69 2021-06-04 03:46
- Guidelines drgunasakaran1 2021-06-07 13:30
  - Guidelines Rams69 2021-06-09 04:43

Registration with CTRI surajpatel 2021-06-02 07:30
- Registration with CTRI drgunasakaran1 2021-06-02 11:39

AUCrefTmax raghup 2021-05-28 12:44
- AUCrefTmax (Health Canada) Helmut 2021-05-28 12:58
  - AUCrefTmax (Health Canada) raghup 2021-05-28 13:16
    - AUCrefTmax (Health Canada) Helmut 2021-05-28 13:23
    - AUCrefTmax (Health Canada) dshah 2021-05-31 10:15

Regulatory Submission in Europe in Absence of Reference product Abhay Patil 2021-03-23 08:58
- Regulatory Submission in Europe in Absence of Reference product dshah 2021-03-23 09:51
  - Regulatory Submission in Europe in Absence of Reference product Abhay Patil 2021-03-23 10:00
    - Regulatory Submission in Europe in Absence of Reference product drgunasakaran1 2021-05-20 07:20

Cataplasms and study design Pharma_88 2021-04-13 06:31
- Cataplasms and study design drgunasakaran1 2021-05-13 06:43

Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria Rams69 2021-05-12 06:57
- Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria ElMaestro 2021-05-12 09:10
  - Why, oh why? Helmut 2021-05-12 10:46
  - Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria Rams69 2021-05-13 04:08
- Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria Ohlbe 2021-05-12 10:51
  - Doubts regarding IS variation, ISR failure & SEL/SPE Acceptance criteria Rams69 2021-05-13 04:09

ICH E6, r3 ElMaestro 2021-04-27 07:45
- CTTI web conferences Ohlbe 2021-04-27 16:59

Retention samples vinodvasala 2021-04-13 13:27
- Retention samples dshah 2021-04-13 19:07

Regulations about bioequivalence studies in Turkey Mohamed Yehia 2021-02-22 17:32
- Regulations about bioequivalence studies in Turkey akif 2021-03-23 06:46
  - Regulations about bioequivalence studies in Turkey Mohamed Yehia 2021-03-28 16:36

Scaling/Widening of AUC Researcher101 2021-02-23 20:40
- Scaling/Widening of AUC Loky do 2021-02-24 13:13
  - RSABE… Helmut 2021-02-24 14:46
    - RSABE… Loky do 2021-02-24 15:30
      - RSABE… Helmut 2021-02-24 15:47
- Scaling/Widening of AUC Helmut 2021-02-24 15:29
  - Scaling/Widening of AUC Loky do 2021-02-24 16:13
  - Scaling/Widening of AUC dshah 2021-03-16 06:39
    - Scaling/Widening of AUC Helmut 2021-03-16 13:55

ANVISA guidelines gsrao2022 2021-03-11 17:50

Retention Vuas 2021-03-05 19:02
- Retention Helmut 2021-03-09 13:38
  - Retention Vuas 2021-03-10 09:46

Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
165 visitors (0 registered, 165 guests [including 25 identified bots]).
Forum time: 17:16 CEST (Europe/Vienna)

Actually, science starts to become interesting
only where it ends. Justus von Liebig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz